Clinical trials
Diabetes Mellitus trials in Taiwan with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 17 |
| Taichung Veterans General Hospital | 5 |
| China Medical University Hospital | 4 |
| Taipei Veterans General Hospital, Taiwan | 3 |
| National Cheng-Kung University Hospital | 2 |
| Taipei Medical University WanFang Hospital | 2 |
| Cardinal Tien Hospital | 1 |
| Chang Gung Memorial Hospital | 1 |
| Chang Gung University of Science and Technology | 1 |
| Concept Medical Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 48 |
| Diabetes Mellitus, Type 2 | 5 |
| Metabolic Diseases | 4 |
| Hypertension | 3 |
| Coronary Artery Disease | 2 |
| Endocrine System Diseases | 2 |
| Glucose Intolerance | 2 |
| Heart Failure | 2 |
| Acute Coronary Syndrome | 1 |
| Alzheimer Disease | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.